INS and metabolic dysfunction-associated steatohepatitis: The use of oral insulin formulation may also affect the immune system by targeting the gut immune system in a way that alleviates systemic inflammation.31, 32, 33 Oral immunotherapy was proposed to alleviate liver damage in MASH.31